7
May
2024

Qilu Pharmaceutical Co.,Ltd.

Exhibitor at CPHI North America 2024 stand 759 & stand CC - 759
About Us

Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, with a footprint in three segments: human medicines, veterinary medicines and crop protection products.

Qilu Pharmaceutical is dedicated to offering high-quality & trustworthy medicines to the world and improving people‘s well-being. 

Qilu Pharmaceutical develops, manufactures and distributes both finished formulations and active pharmaceutical ingredients.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 5000+
    Employees
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI North America 2024
  • 07 May 2024 - 09 May 2024
  • Pennsylvania Convention Center, Philadelphia
  • Visit us at stand 759

Products Featured at CPHI North America 2024

  • Amikacin Sulfate

    Product Amikacin Sulfate

    Qilu Pharmaceutical Co., Ltd offers wide range of formulations which includes amikacin sulfate. Therapeutic category: anti-infective. Form: solution. Contact us for more information.
  • Aripiprazole

    Product Aripiprazole

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes aripiprazole. Therapeutic category: psychological. Contact us for more information.
  • Bortezomib

    Product Bortezomib

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes bortezomib. Therapeutic category: oncology. Contact us for more information.
  • Capecitabine

    Product Capecitabine

    Qilu Pharmaceutical Co., Ltd offers wide range of API which includes capecitabine. Therapeutic category: oncology. Contact us for more information.
  • Carboplatin

    Product Carboplatin

    Qilu Pharmaceutical Co., Ltd offers wide range of formulations which includes carboplatin. Therapeutic category: oncology. Form: injectable. Contact us for more information.